GATEWAY INVESTMENT ADVISERS LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1114618 CINCINNATI, OH

Position in NBIX

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$203,596

New position

Shares Held

1,208

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#602

of 768 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GATEWAY INVESTMENT ADVISERS LLC holds $3,587,856 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	104,289	$1,656,109
2	UTHR	UNITED THERAPEUTICS Corp	2,572	$1,393,586
3	TEVA	Teva Pharmaceutical Industries Ltd	9,875	$334,565
4	NBIX	Neurocrine Biosciences Inc This page	1,208	$203,596

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$203,596	1,208	—	Shares	Sole	2026-07-20
No filing history on record for this holder in this stock.